-+ 0.00%
-+ 0.00%
-+ 0.00%

Reviva Pharmaceuticals Reports Phase 3 Success for Brilaroxazine in Treating Schizophrenia Negative Symptoms

Reuters·01/08/2026 13:02:38

Please log in to view news